Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

XOMA Corporation (XOMA)

-NasdaqGM
3.88 Down 0.18(4.43%) 4:00PM EDT
Prev Close:4.06
Open:3.96
Bid:3.81 x 500
Ask:3.89 x 100
1y Target Est:9.00
Beta:2.71
Next Earnings Date: 7-Aug-14XOMA Earnings announcement
Day's Range:3.85 - 4.06
52wk Range:3.42 - 9.57
Volume:1,239,068
Avg Vol (3m):1,520,350
Market Cap:414.76M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 4.43%414.76M
NVSDown 1.70%210.93B
REGNDown 1.85%31.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback